S
Sally Burrows-Hudson
Researcher at Amgen
Publications - 9
Citations - 14844
Sally Burrows-Hudson is an academic researcher from Amgen. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 9, co-authored 9 publications receiving 14701 citations. Previous affiliations of Sally Burrows-Hudson include National Academy of Sciences & Tufts University.
Papers
More filters
Journal ArticleDOI
Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects
George R. Bailie,George Eisele,Lei Liu,Erik Roys,Margaret Kiser,Frederick Finkelstein,Robert R. Wolfe,Friedrich K. Port,Sally Burrows-Hudson,Rajiv Saran +9 more
TL;DR: Substantial underutilization of certain classes of cardioprotective medications is apparent, and systematic educational efforts in this direction may well prove worthwhile to impact outcomes.
Journal ArticleDOI
Measuring, managing, and improving quality in the end-stage renal disease treatment setting: committee statement.
Robert W. Schrier,Sally Burrows-Hudson,Louis H. Diamond,A. Peter Lundin,Maureen Michael,Donald L. Patrick,Thomas G. Peters,Neil R. Powe,James S. Roberts,John H. Sadler,Albert L. Siu,Kathleen N. Lohr,Richard A. Rettig +12 more
TL;DR: The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution.
Journal ArticleDOI
The longitudinal chronic kidney disease study: a prospective cohort study of predialysis renal failure.
Rachel L. Perlman,Margaret Kiser,Fredric O. Finkelstein,George Eisele,Erik Roys,Lei Liu,Sally Burrows-Hudson,Friedrich Port,Joseph M. Messana,George R. Bailie,Sanjay Rajagopalan,Rajiv Saran +11 more
TL;DR: The LCKD Study is a multicenter, prospective, observational study of patients with moderate to severe CKD that was designed to better describe the course of the disease and the determinants of patient outcomes.
Journal ArticleDOI
The Study of Treatment for Renal Insufficiency: Data and Evaluation (STRIDE), a national registry of chronic kidney disease.
Madhumathi Rao,Annamaria T. Kausz,Don Mitchell,Sari Heller Ratican,Francie Lin,Sally Burrows-Hudson,Fritz Port,Brian J.G. Pereira +7 more
TL;DR: The Study of Treatment for Renal Insufficiency: Data and Evaluation (STRIDE) registry is an initiative to study CKD patients in nephrology practices across the country, a prospective observational study whose objective is to profile demographic and clinical variables, practice patterns, comorbid conditions, quality of life, and outcomes in a nationally based sample of CKD Patients.